Your browser doesn't support javascript.
loading
Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.
Chakraborty, Nayanika; Jha, Diksha; Roy, Indrajit; Kumar, Pradeep; Gaurav, Shailendra Singh; Marimuthu, Kalisvar; Ng, Oon-Tek; Lakshminarayanan, Rajamani; Verma, Navin Kumar; Gautam, Hemant K.
Afiliación
  • Chakraborty N; Department of Chemistry, University of Delhi, New Delhi, 110007, India.
  • Jha D; Department of Immunology and Infectious Disease Biology, CSIR-Institute of Genomics and Integrative Biology, Sukhdev Vihar, New Delhi, 110025, India.
  • Roy I; Department of Immunology and Infectious Disease Biology, CSIR-Institute of Genomics and Integrative Biology, Sukhdev Vihar, New Delhi, 110025, India.
  • Kumar P; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Gaurav SS; Department of Chemistry, University of Delhi, New Delhi, 110007, India.
  • Marimuthu K; CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi University Campus, 110007, New Delhi, India.
  • Ng OT; Department of Genetics and Plant Breeding, Faculty of Agriculture, Chaudhary Charan Singh University, Meerut, 250004, India.
  • Lakshminarayanan R; National Centre for Infectious Diseases (NCID), Singapore, 308442, Singapore.
  • Verma NK; Tan Tock Seng Hospital (TTSH), 308433, Singapore, Singapore.
  • Gautam HK; National Centre for Infectious Diseases (NCID), Singapore, 308442, Singapore.
J Nanobiotechnology ; 20(1): 375, 2022 Aug 12.
Article en En | MEDLINE | ID: mdl-35953826
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Antiinfecciosos Límite: Humans Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Antiinfecciosos Límite: Humans Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: India